Past studies have revealed that intravenous PG I2 given before ischemia reduced infarct size and administration of COX-2 inhibitors before infarction hindered the infarct size-limiting effects of late ischemic preconditioning [28]. This evidence concerns the gene PTGS2 and infarction.